Q-linea AB (Publ) announced that the company has entered into an agreement with Labema Oy for ASTar® Instrument and consumables in Finland and the Baltic States. With the appointment of Labema Oy, Q-linea continues to grow its European sales network. Q-linea already has representation, direct or through partners, in the following countries: France, Italy, Norway, Poland, Sweden, and the UK.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 SEK | -2.16% | -7.72% | -38.65% |
Apr. 26 | Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System | CI |
Mar. 13 | Q-linea AB Presents Strong ASTar Results At AMCLI | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.65% | 24.95M | |
-16.33% | 18.83B | |
-42.28% | 2.92B | |
+22.02% | 1.9B | |
+0.39% | 1.71B | |
+27.15% | 1.26B | |
-10.70% | 1.04B | |
-18.27% | 961M | |
+0.66% | 779M | |
-25.12% | 649M |
- Stock Market
- Equities
- QLINEA Stock
- News Q-linea AB
- Q-Linea AB Strengthens its Presence in Finland and the Baltics Through Partnership with Labema Oy